Literature DB >> 24876935

The role of induction therapy.

Jacob R Moremen1, Elaine N Skopelja1, DuyKhanh P Ceppa1.   

Abstract

The incidence of esophageal cancer has been steadily increasing. The 5-year survival of esophageal cancer has minimally improved over the past 30 years. In this article, we review the management of esophageal cancer, focusing on the literature investigating the role of induction chemotherapy and radiation therapy.

Entities:  

Keywords:  Esophageal cancer; chemotherapy; radiation therapy; trimodality therapy

Year:  2014        PMID： 24876935      PMCID： PMC4037412          DOI： 10.3978/j.issn.2072-1439.2014.03.10

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  16 in total

1.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Authors:  Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

2.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

3.  A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).

Authors:  Nobutoshi Ando; Hoichi Kato; Hiroyasu Igaki; Masayuki Shinoda; Soji Ozawa; Hideaki Shimizu; Tsutomu Nakamura; Hiroshi Yabusaki; Norio Aoyama; Akira Kurita; Kenichiro Ikeda; Tatsuo Kanda; Toshimasa Tsujinaka; Kenichi Nakamura; Haruhiko Fukuda
Journal:  Ann Surg Oncol       Date:  2011-08-31       Impact factor: 5.344

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial.

Authors:  Bryan H Burmeister; Janine M Thomas; Elizabeth A Burmeister; Euan T Walpole; Jennifer A Harvey; Damien B Thomson; Andrew P Barbour; David C Gotley; B Mark Smithers
Journal:  Eur J Cancer       Date:  2011-02       Impact factor: 9.162

6.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.

Authors:  Bruce D Minsky; Thomas F Pajak; Robert J Ginsberg; Thomas M Pisansky; James Martenson; Ritsuko Komaki; Gordon Okawara; Seth A Rosenthal; David P Kelsen
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

7.  Endoscopic ultrasound errors in esophageal cancer.

Authors:  Gregory Zuccaro; Thomas W Rice; John J Vargo; John R Goldblum; Lisa A Rybicki; John A Dumot; David J Adelstein; Patricia A Trolli; Eugene H Blackstone
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

8.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.

Authors:  Nobutoshi Ando; Toshifumi Iizuka; Hiroko Ide; Kaoru Ishida; Masayuki Shinoda; Tadashi Nishimaki; Wataru Takiyama; Hiroshi Watanabe; Kaichi Isono; Norio Aoyama; Hiroyasu Makuuchi; Otsuo Tanaka; Hideaki Yamana; Shunji Ikeuchi; Toshiyuki Kabuto; Kagami Nagai; Yutaka Shimada; Yoshihide Kinjo; Haruhiko Fukuda
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

9.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

10.  Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery.

Authors:  A J Sykes; P A Burt; N J Slevin; R Stout; J E Marrs
Journal:  Radiother Oncol       Date:  1998-07       Impact factor: 6.280
View more
  2 in total

1.  Substernal reconstruction following esophagectomy: operation of last resort?

Authors:  Jacob R Moremen; DuyKhanh P Ceppa; Karen M Rieger; Thomas J Birdas
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design.

Authors:  Yingpeng Li; Xiuyan Li; Qingxia Guan; Chunjing Zhang; Ting Xu; Yujing Dong; Xinyu Bai; Weiping Zhang
Journal:  Int J Nanomedicine       Date:  2017-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.